Literature DB >> 22134520

Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome.

Matthias Mueller1, Moritz Biener, Mehrshad Vafaie, Susanne Doerr, Till Keller, Stefan Blankenberg, Hugo A Katus, Evangelos Giannitsis.   

Abstract

BACKGROUND: We evaluated kinetic changes of high-sensitivity cardiac troponin T (hs-cTnT) in patients with acute coronary syndrome (ACS) and patients with hs-cTnT increases not due to ACS to rule in or rule out non-ST-segment elevation myocardial infarction (STEMI).
METHODS: hs-cTnT was measured serially in consecutive patients presenting to the emergency department. Patients with ACS who had at least 2 hs-cTnT measurements within 6 h and non-ACS patients with hs-cTnT concentrations above the 99th percentile value (14 ng/L) were enrolled to compare absolute and relative kinetic changes of hs-cTnT.
RESULTS: For discrimination of non-STEMI (n=165) in the entire study population (n=784), the absolute δ change with the ROC-optimized value of 9.2 ng/L yielded an area under the curve of 0.898 and was superior to all relative δ changes (P<0.0001). The positive predictive value for the absolute δ change was 48.7%, whereas the negative predictive value was 96.5%. In a specific ACS population with exclusion of STEMI (n=342), the absolute δ change with the ROC-optimized value of 6.9 ng/L yielded a positive predictive value of 82.8% and a negative predictive value of 93.0%. In comparison to the ≥20% relative δ change, the ROC-optimized absolute δ change demonstrated a significantly added value for the entire study population and for the ACS cohort (net reclassification index 0.331 and 0.499, P<0.0001).
CONCLUSIONS: Absolute δ changes appear superior to relative δ changes in discriminating non-STEMI. A rise or fall of at least 9.2 ng/L in the entire study population and 6.9 ng/L in selected ACS patients seems adequate to rule-out non-STEMI. However, δ-values are useful to rule-in non-STEMI only in a specific ACS population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22134520     DOI: 10.1373/clinchem.2011.171827

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  40 in total

1.  Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population.

Authors:  Moritz Biener; Matthias Mueller; Mehrshad Vafaie; Allan S Jaffe; Christian Widera; Hugo A Katus; Evangelos Giannitsis
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-07-15

Review 2.  Biological and analytical variation of clinical biomarker testing: implications for biomarker-guided therapy.

Authors:  Alan H B Wu
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 3.  The evolving role of cardiac troponin in the evaluation of cardiac disorders.

Authors:  Paul Anaya; David J Moliterno
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

4.  Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay.

Authors:  Tobias Reichlin; Raphael Twerenbold; Karin Wildi; Maria Rubini Gimenez; Nathalie Bergsma; Philip Haaf; Sophie Druey; Christian Puelacher; Berit Moehring; Michael Freese; Claudia Stelzig; Lian Krivoshei; Petra Hillinger; Cedric Jäger; Thomas Herrmann; Philip Kreutzinger; Milos Radosavac; Zoraida Moreno Weidmann; Kateryna Pershyna; Ursina Honegger; Max Wagener; Thierry Vuillomenet; Isabel Campodarve; Roland Bingisser; Òscar Miró; Katharina Rentsch; Stefano Bassetti; Stefan Osswald; Christian Mueller
Journal:  CMAJ       Date:  2015-04-13       Impact factor: 8.262

5.  Pros and cons of high-sensitivity assays for cardiac troponin.

Authors:  Evangelos Giannitsis; Hugo A Katus
Journal:  Nat Rev Cardiol       Date:  2012-10-02       Impact factor: 32.419

6.  Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome.

Authors:  M Mueller; S Celik; M Biener; M Vafaie; K Schwoebel; K C Wollert; J L Januzzi; H A Katus; E Giannitsis
Journal:  Clin Res Cardiol       Date:  2012-05-25       Impact factor: 5.460

7.  Typical rise and fall of troponin in (peri-procedural) myocardial infarction: A systematic review.

Authors:  Dianne van Beek; Bas van Zaane; Marjolein Looije; Linda Peelen; Wilton van Klei
Journal:  World J Cardiol       Date:  2016-03-26

Review 8.  Revisiting the Biological Variability of Cardiac Troponin: Implications for Clinical Practice.

Authors:  Nick S R Lan; Damon A Bell
Journal:  Clin Biochem Rev       Date:  2019-11

Review 9.  High-sensitivity cardiac troponins in everyday clinical practice.

Authors:  Johannes Mair
Journal:  World J Cardiol       Date:  2014-04-26

10.  [Essential cardiac biomarkers in myocardial infarction and heart failure].

Authors:  M Mueller; E Giannitsis; H A Katus
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.